VOR – vor biopharma inc. (US:NASDAQ)
Stock Stats
News
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock, down previously from $15.00.
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
Vor Bio to Participate in Upcoming Investor Conferences
Form 10-Q Vor Biopharma Inc. For: Mar 31
Form 4 Vor Biopharma Inc. For: May 06 Filed by: Attar Eyal C.
Form 4 Vor Biopharma Inc. For: May 06 Filed by: ANG ROBERT
Form 4 Vor Biopharma Inc. For: May 06 Filed by: Chakraborty Tirtha
Form 4 Vor Biopharma Inc. For: May 06 Filed by: Jorgensen Nathan D.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.